As of January 23, 2025, bioAffinity Technologies (BIAF) has a market cap of $10.364 million USD. According to our data, bioAffinity Technologies is ranked No.8849 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $10.36 M |
-26.92%
|
Dec 31, 2024 | $14.18 M |
-38.14%
|
Dec 29, 2023 | $22.92 M |
-8.06%
|
Dec 30, 2022 | $24.94 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
QuidelOrtho
QDEL
|
$2.99 B |
-0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Hologic
HOLX
|
$16.07 B |
-0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
Market Cap | = | BIAF Stock Price | * | BIAF Shares Outstanding |
= | $0.67 | * | 15.58 M | |
= | $10.36 M |